Infinity Pharmaceuticals Documents
Documents
15
Ticker
INFIQ
ISIN
US45665G3039
Infinity Pharmaceuticals SEC Filings
Type | Report | Date |
|---|---|---|
| 25-NSE | 25-NSE-Formular | 11/20/2023 |
| 8-K | Allgemeines, mitteilungspflichtiges Informationsschreiben | 9/29/2023 |
| 8-K | Allgemeines, mitteilungspflichtiges Informationsschreiben | 9/13/2023 |
| 4 | Insidertransaktion | 9/12/2023 |
| 8-K | Allgemeines, mitteilungspflichtiges Informationsschreiben | 9/11/2023 |
| 8-K | Allgemeines, mitteilungspflichtiges Informationsschreiben | 9/1/2023 |
| 10-Q | Quartalsbericht | 8/10/2023 |
| 8-K | Allgemeines, mitteilungspflichtiges Informationsschreiben | 7/25/2023 |
| 8-K | Allgemeines, mitteilungspflichtiges Informationsschreiben | 7/24/2023 |
| 8-K | Allgemeines, mitteilungspflichtiges Informationsschreiben | 7/14/2023 |
| DEFA14A | DEFA14A-Formular | 7/10/2023 |
| DEFA14A | DEFA14A-Formular | 7/5/2023 |
| 425 | 425-Formular | 7/3/2023 |
| 8-K | Allgemeines, mitteilungspflichtiges Informationsschreiben | 7/3/2023 |
| DEFA14A | DEFA14A-Formular | 7/3/2023 |
Infinity Pharmaceuticals Documents 2026
This page contains all official documents and SEC filings for Infinity Pharmaceuticals stock (INFIQ, ISIN: US45665G3039). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 15 documents are available. Data is updated regularly to provide investors with a complete overview of Infinity Pharmaceuticals's regulatory filings.
Infinity Pharmaceuticals Stock analysis
Infinity Pharmaceuticals Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases.